Related Experiment Videos
Fundus changes in patients with the mitochondrial DNA point mutation at position 3243
1Department of Ophthalmology, University Hospitals of Leuven, Belgium.
Bulletin De La Societe Belge D'Ophtalmologie
|January 1, 1996
Summary
The A3243G mitochondrial DNA mutation is linked to MELAS syndrome. Macular pattern dystrophy in diabetic patients may indicate this mutation, prompting genetic screening.
Area of Science:
- Genetics
- Ophthalmology
- Neurology
Background:
- The A3243G mitochondrial DNA mutation is a known cause of MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes).
- Ocular manifestations, including atypical pigmentary retinopathy, have been observed in patients with this mutation.
- Maternally inherited diabetes and deafness is a recognized phenotype associated with the A3243G mutation.
Observation:
- A pattern dystrophy has been identified as a characteristic ocular abnormality in patients with maternally inherited diabetes and deafness due to the A3243G mutation.
- This macular pattern dystrophy can serve as a clinical indicator for the underlying mitochondrial defect.
Findings:
- The presence of macular pattern dystrophy in individuals with diabetes warrants investigation for the A3243G mitochondrial DNA mutation.
- This finding links a specific ocular sign to a distinct clinical presentation of mitochondrial disease.
Implications:
- Screening for the A3243G mitochondrial genome should be considered in diabetic patients presenting with macular pattern dystrophy.
- Early identification of this mitochondrial defect can facilitate timely diagnosis and management of associated conditions.
- This research highlights the importance of ophthalmological examination in the broader diagnostic workup of mitochondrial disorders.